OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
21442060

Tonymoly Co Ltd

Personal ProductsVerified

Capital Structure and Liquidity Tonymoly maintains a debt-to-equity ratio of 0.56, indicating a moderate reliance on debt financing. The company's liquidity position is characterized as medium, with a current ratio of 0.98, suggesting that its current liabilities slightly exceed its current assets. The company's cash and equivalents amount to 8,890.33 million KRW, while its long-term debt stands at 65,918.35 million KRW, resulting in a net cash position that is negative after subtracting total debt. ### Profitability and Returns Tonymoly's return on equity (ROE) is 9.43%, and its return on assets (ROA) is 4.91%. These figures suggest that the company is generating a reasonable return for its shareholders and effectively utilizing its assets to generate profit. The company's net income of 11,130.72 million KRW and operating income of 12,825.64 million KRW further support its profitability. ### Segments and Geographic Exposure Tonymoly operates through three segments: Cosmetics, Pet, and New Technology Business Finance. The Cosmetics Business segment is the primary revenue driver, focusing on facial cleansing and moisturizing products. The Pet Business segment provides pet supplies and food, while the New Technology Business Finance segment engages in venture and fund investments. The company's geographic exposure is primarily concentrated in South Korea, with no significant international revenue disclosed. ### Growth Trajectory Tonymoly's revenue for the latest period is 220,273.59 million KRW. While the company's growth trajectory is not explicitly detailed in the provided data, the absence of a strong buy recommendation from analysts and the moderate recommendation of 2.00 suggest a cautious outlook. The company's capital expenditure of -6,801.69 million KRW indicates a reduction in investment in physical assets, which may affect future growth. ### Risk Factors The company faces a medium liquidity risk, as indicated by its current ratio of 0.98. The risk assessment also highlights a key flag of negative net cash after subtracting total debt, which could impact the company's ability to meet short-term obligations. The dilution risk is assessed as low, with no significant dilution potential identified in the data provided. ### Recent Events Recent events and filings do not show any significant changes in the company's operations or financial structure. The company's recent financial performance and strategic direction appear to be stable, with no major disruptions reported in the latest data.

30-day price · 214420+400.00 (+5.9%)
Low$6200.00High$8350.00Close$7130.00As of12 May, 00:00 UTC
Profile
CompanyTonymoly Co Ltd
Ticker214420.KS
SectorConsumer Non-Cyclicals
BusinessPersonal & Household Products & Services
Industry groupPersonal & Household Products & Services
IndustryPersonal Products
AI analysis

Business. Tonymoly Co Ltd is a Korea-based company primarily engaged in the manufacture of cosmetics, operating through three segments: Cosmetics, Pet, and New Technology Business Finance.

Classification. Tonymoly is classified under the Consumer Non-Cyclicals economic sector, Personal & Household Products & Services business sector, and Personal Products industry with a confidence level of 0.92.

### Capital Structure and Liquidity Tonymoly maintains a debt-to-equity ratio of 0.56, indicating a moderate reliance on debt financing. The company's liquidity position is characterized as medium, with a current ratio of 0.98, suggesting that its current liabilities slightly exceed its current assets. The company's cash and equivalents amount to 8,890.33 million KRW, while its long-term debt stands at 65,918.35 million KRW, resulting in a net cash position that is negative after subtracting total debt. ### Profitability and Returns Tonymoly's return on equity (ROE) is 9.43%, and its return on assets (ROA) is 4.91%. These figures suggest that the company is generating a reasonable return for its shareholders and effectively utilizing its assets to generate profit. The company's net income of 11,130.72 million KRW and operating income of 12,825.64 million KRW further support its profitability. ### Segments and Geographic Exposure Tonymoly operates through three segments: Cosmetics, Pet, and New Technology Business Finance. The Cosmetics Business segment is the primary revenue driver, focusing on facial cleansing and moisturizing products. The Pet Business segment provides pet supplies and food, while the New Technology Business Finance segment engages in venture and fund investments. The company's geographic exposure is primarily concentrated in South Korea, with no significant international revenue disclosed. ### Growth Trajectory Tonymoly's revenue for the latest period is 220,273.59 million KRW. While the company's growth trajectory is not explicitly detailed in the provided data, the absence of a strong buy recommendation from analysts and the moderate recommendation of 2.00 suggest a cautious outlook. The company's capital expenditure of -6,801.69 million KRW indicates a reduction in investment in physical assets, which may affect future growth. ### Risk Factors The company faces a medium liquidity risk, as indicated by its current ratio of 0.98. The risk assessment also highlights a key flag of negative net cash after subtracting total debt, which could impact the company's ability to meet short-term obligations. The dilution risk is assessed as low, with no significant dilution potential identified in the data provided. ### Recent Events Recent events and filings do not show any significant changes in the company's operations or financial structure. The company's recent financial performance and strategic direction appear to be stable, with no major disruptions reported in the latest data.
Key takeaways
  • Tonymoly maintains a moderate debt-to-equity ratio of 0.56, indicating a balanced capital structure.
  • The company's ROE of 9.43% and ROA of 4.91% suggest strong profitability and efficient asset utilization.
  • Tonymoly's primary business is in the cosmetics segment, with additional ventures in pet supplies and finance.
  • The company's liquidity position is medium, with a current ratio of 0.98 and a negative net cash position after debt.
  • Analysts have a moderate outlook on Tonymoly, with a mean recommendation of 2.00 and a price target of 10,500 KRW.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyKRW
Revenue$220.27B
Gross profit$93.44B
Operating income$12.83B
Net income$11.13B
R&D
SG&A
D&A
SBC
Operating cash flow$9.43B
CapEx-$6.80B
Free cash flow$7.98B
Total assets$226.60B
Total liabilities$108.57B
Total equity$118.03B
Cash & equivalents$8.89B
Long-term debt$65.92B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$118.03B
Net cash-$57.03B
Current ratio1.0
Debt/Equity0.6
ROA4.9%
ROE9.4%
Cash conversion85.0%
CapEx/Revenue-3.1%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Personal Products · cohort 225 companies
Metric214420Activity
Op margin5.8%16.2% medp25 16.2% · p75 16.2%bottom quartile
Net margin5.1%10.5% medp25 10.5% · p75 10.5%bottom quartile
Gross margin42.4%60.1% medp25 60.1% · p75 60.1%bottom quartile
R&D / revenue1.8% medp25 1.8% · p75 1.8%
CapEx / revenue-3.1%-2.3% medp25 -4.4% · p75 -1.1%below median
Debt / equity56.0%12724.1% medp25 12724.1% · p75 12724.1%bottom quartile
Observations
IR observations
Mean price target10,500.00 KRW
Median price target10,500.00 KRW
High price target10,500.00 KRW
Low price target10,500.00 KRW
Mean recommendation2.00 (1=strong buy, 5=strong sell)
Strong-buy count0.00
Buy count1.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate1,009.00 KRW
Last actual EPS466.00 KRW
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 12:07 UTC#a9269e81
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 12:10 UTCJob: deac5f56